Video

Areas Pharmacists Should Focus on when Raising Awareness of Resistant Pathogens

Jason Gallagher, PharmD, FCCP, a clinical pharmacy specialist of infectious diseases at Temple University, discusses areas pharmacists should focus on when raising awareness of resistant pathogens.

Jason Gallagher, PharmD, FCCP, a clinical pharmacy specialist of infectious diseases at Temple University, discusses areas pharmacists should focus on when raising awareness of resistant pathogens.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Related Content
Cropped of black man receiving vaccine shot
June 20th 2025

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Luke Halpern, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Sunscreen lotion in sun shape on tanned woman's shoulder - Image credit: sosiukin | stock.adobe.com
June 20th 2025

OTC Case Studies: Summer Skin Care

Sneha Baxi Srivastava, PharmD, BCACP, CDCES, DipACLM, FADCES Rupal Patel Mansukhani, PharmD, FAPhA, NCTTP
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Nonpharmacist Membership on Boards of Pharmacy Continues to Expand
June 19th 2025

Nonpharmacist Membership on Boards of Pharmacy Continues to Expand

Marilyn N. Bulloch, PharmD, BCPS, FCCM, SPP
FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
June 19th 2025

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

Gillian McGovern, Associate Editor